Novel Topical Application of a Postbiotic, LactoSporin®, in Mild to Moderate Acne: A Randomized, Comparative Clinical Study to Evaluate its Efficacy, Tolerability and Safety
Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin® 2% w/w cream with benzoyl peroxide in 64 male...
Saved in:
Published in | Cosmetics (Basel) Vol. 7; no. 3; p. 70 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
MDPI AG
01.09.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 2079-9284 2079-9284 |
DOI | 10.3390/cosmetics7030070 |
Cover
Abstract | Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin® 2% w/w cream with benzoyl peroxide in 64 male and female subjects with mild-to-moderate acne for three weeks. The efficacy parameters were evaluated based on the dermatologist visual assessment and instrumental measurements using Sebumeter® MPA580, Antera 3DTM and VISIA CR 2.2 and subject self-assessment questionnaires. Adverse events were recorded throughout the study period. In order to understand the mechanism of action and properties of LactoSporin, the pH stability, thermostability, antimicrobial activity and 5-alpha reductase activity were evaluated in vitro. A significant improvement was observed in the dermatological assessment of closed comedones (p < 0.0001), open comedones (p = 0.0069) and papules count (p < 0.0001) in comparison to the baseline in both LactoSporin and benzoyl peroxide groups. The antera analysis showed significant improvement in redness (p < 0.0001) and elevation (p < 0.0001) (small and medium) in both the treatment groups. The sebumeter analysis showed a significant decrease in sebaceous secretion (p < 0.0001) for LactoSporin, which resulted in reduced oiliness, pimples, acne spots and redness around the acne spot. The product was found to be safe without any irritancy. LactoSporin was stable at an acidic pH and temperature range of 70 to 90 °C, with antimicrobial activity against various pathogenic bacteria, including Cutibacterium acnes. It was also a potent inhibitor of 5-alpha reductase activity. Thus, it can be concluded that the efficacy of LactoSporin is equivalent to benzoyl peroxide in the treatment of mild-to-moderate acne lesions and better than benzoyl peroxide for reducing the sebaceous secretion and oily, greasy nature of the skin, implying its efficacy in other sebohorriec conditions. |
---|---|
AbstractList | Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin[R] 2% w/w cream with benzoyl peroxide in 64 male and female subjects with mild-to-moderate acne for three weeks. The efficacy parameters were evaluated based on the dermatologist visual assessment and instrumental measurements using Sebumeter[R] MPA580, Antera 3D (TM) and VISIA CR 2.2 and subject self-assessment questionnaires. Adverse events were recorded throughout the study period. In order to understand the mechanism of action and properties of LactoSporin, the pH stability, thermostability, antimicrobial activity and 5-alpha reductase activity were evaluated in vitro. A significant improvement was observed in the dermatological assessment of closed comedones (p < 0.0001), open comedones (p = 0.0069) and papules count (p < 0.0001) in comparison to the baseline in both LactoSporin and benzoyl peroxide groups. The antera analysis showed significant improvement in redness (p < 0.0001) and elevation (p < 0.0001) (small and medium) in both the treatment groups. The sebumeter analysis showed a significant decrease in sebaceous secretion (p < 0.0001) for LactoSporin, which resulted in reduced oiliness, pimples, acne spots and redness around the acne spot. The product was found to be safe without any irritancy. LactoSporin was stable at an acidic pH and temperature range of 70 to 90 [degrees]C, with antimicrobial activity against various pathogenic bacteria, including Cutibacterium acnes. It was also a potent inhibitor of 5-alpha reductase activity. Thus, it can be concluded that the efficacy of LactoSporin is equivalent to benzoyl peroxide in the treatment of mild-to-moderate acne lesions and better than benzoyl peroxide for reducing the sebaceous secretion and oily, greasy nature of the skin, implying its efficacy in other sebohorriec conditions. Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin® 2% w/w cream with benzoyl peroxide in 64 male and female subjects with mild-to-moderate acne for three weeks. The efficacy parameters were evaluated based on the dermatologist visual assessment and instrumental measurements using Sebumeter® MPA580, Antera 3DTM and VISIA CR 2.2 and subject self-assessment questionnaires. Adverse events were recorded throughout the study period. In order to understand the mechanism of action and properties of LactoSporin, the pH stability, thermostability, antimicrobial activity and 5-alpha reductase activity were evaluated in vitro. A significant improvement was observed in the dermatological assessment of closed comedones (p < 0.0001), open comedones (p = 0.0069) and papules count (p < 0.0001) in comparison to the baseline in both LactoSporin and benzoyl peroxide groups. The antera analysis showed significant improvement in redness (p < 0.0001) and elevation (p < 0.0001) (small and medium) in both the treatment groups. The sebumeter analysis showed a significant decrease in sebaceous secretion (p < 0.0001) for LactoSporin, which resulted in reduced oiliness, pimples, acne spots and redness around the acne spot. The product was found to be safe without any irritancy. LactoSporin was stable at an acidic pH and temperature range of 70 to 90 °C, with antimicrobial activity against various pathogenic bacteria, including Cutibacterium acnes. It was also a potent inhibitor of 5-alpha reductase activity. Thus, it can be concluded that the efficacy of LactoSporin is equivalent to benzoyl peroxide in the treatment of mild-to-moderate acne lesions and better than benzoyl peroxide for reducing the sebaceous secretion and oily, greasy nature of the skin, implying its efficacy in other sebohorriec conditions. |
Audience | Academic |
Author | Majeed, Shaheen Mundkur, Lakshmi Nagabhushanam, Kalyanam Beede, Kirankumar Majeed, Muhammed Rajalakshmi, H. Shah, Kalpesh |
Author_xml | – sequence: 1 givenname: Muhammed surname: Majeed fullname: Majeed, Muhammed – sequence: 2 givenname: Shaheen orcidid: 0000-0001-6400-8245 surname: Majeed fullname: Majeed, Shaheen – sequence: 3 givenname: Kalyanam orcidid: 0000-0001-9470-4110 surname: Nagabhushanam fullname: Nagabhushanam, Kalyanam – sequence: 4 givenname: Lakshmi orcidid: 0000-0003-2928-1726 surname: Mundkur fullname: Mundkur, Lakshmi – sequence: 5 givenname: H. surname: Rajalakshmi fullname: Rajalakshmi, H. – sequence: 6 givenname: Kalpesh surname: Shah fullname: Shah, Kalpesh – sequence: 7 givenname: Kirankumar orcidid: 0000-0001-7190-6385 surname: Beede fullname: Beede, Kirankumar |
BookMark | eNp1kc1q3DAUhU1JoWmafZeCbmdayZJlq7thmDSBSVs66dpc6ycoyL7GUgbch8pD9MmimSmlBLrSRfec7widt8XZgIMtiveMfuRc0U8aY2-T17GmnNKavirOS1qrpSobcfbP_Ka4jPGBUsp4WXGmzounr7i3gdzh6DUEshrHkIfkcSDoCJDvGFPnMbMXZAs64W7EyQ-_nxbED-TWB0MSkls0doJkyUoP9jNZkR8wGOz9L2sWZI39CHnr95asgx-OQbv0aOaDdbOH8Hiw-hTJxrm81fMiPyhkYueDTzPJMLIDZ9P8rnjtIER7-ee8KH5ebe7W18vtty8369V2qXmt0pJxzk3lNKXSGNbVgjPJrWuaRmolpTQArpJWQiPLTpYVSG5M54SsS1WJSvGL4ubENQgP7Tj5Hqa5RfDt8QKn-xam_CnBtkCZggwWHauFVUJRaktdN9wIWgrhMuvDiXUPWe4Hh2kC3fuo25UUsmKyVCyr6EmlJ4xxsu5vKqPtoeT2ZcnZIl9YtE_H7nKAD_83PgOYZLFX |
CitedBy_id | crossref_primary_10_1080_19490976_2022_2117508 crossref_primary_10_20479_bursauludagziraat_1485713 crossref_primary_10_3390_fermentation9030264 crossref_primary_10_3390_microorganisms11061420 crossref_primary_10_3390_ijms22084228 crossref_primary_10_3390_cosmetics9030065 crossref_primary_10_3390_antibiotics12121698 crossref_primary_10_4014_jmb_2403_03010 crossref_primary_10_1111_ics_12766 crossref_primary_10_33320_maced_pharm_bull_2022_68_01_002 crossref_primary_10_1080_09546634_2023_2296855 crossref_primary_10_3389_fsufs_2022_887642 crossref_primary_10_1007_s12602_023_10175_2 crossref_primary_10_2174_0113816128335414240828105229 crossref_primary_10_1080_14728214_2022_2110239 crossref_primary_10_1093_jambio_lxad274 crossref_primary_10_1186_s13040_025_00433_0 crossref_primary_10_1097_MD_0000000000040931 crossref_primary_10_2147_CCID_S403418 crossref_primary_10_1002_biof_1975 crossref_primary_10_3390_app12189151 crossref_primary_10_1080_10408398_2020_1865260 crossref_primary_10_3390_cosmetics7040076 crossref_primary_10_1007_s12275_022_00002_8 crossref_primary_10_2174_1573401319666230309122819 crossref_primary_10_4103_ijd_ijd_655_22 crossref_primary_10_3390_vaccines11040725 crossref_primary_10_1080_10408398_2022_2056727 crossref_primary_10_3389_fmicb_2023_1306192 crossref_primary_10_3390_nu16203559 crossref_primary_10_3390_biomedicines13040791 crossref_primary_10_1016_j_jddst_2024_105635 crossref_primary_10_1111_jam_15663 crossref_primary_10_1111_jocd_15809 crossref_primary_10_26599_FSHW_2022_9250217 crossref_primary_10_1016_j_procbio_2024_05_010 |
Cites_doi | 10.1111/j.1529-8019.2006.00079.x 10.1016/B978-0-12-812475-8.00004-4 10.1111/1346-8138.14314 10.1016/j.clp.2012.12.002 10.1128/AEM.05576-11 10.4161/derm.3.1.13900 10.1126/science.1225152 10.1016/S0378-1097(03)00092-2 10.1007/s12275-008-0179-y 10.5694/mja16.00516 10.1111/pde.13261 10.1046/j.1472-765x.2001.00876.x 10.15171/hpp.2020.02 10.3390/ijms20194673 10.1111/j.1468-2494.2011.00647.x 10.1016/j.drudis.2016.10.017 10.1590/abd1806-4841.20142100 10.1016/j.clim.2015.05.014 10.1016/j.ijwd.2015.02.001 10.1007/s007950100002 10.1136/bmj.1.6171.1109 10.1111/bjd.13462 10.1016/S0140-6736(98)01046-0 10.1111/j.1468-3083.2011.04374.x 10.1016/S0168-1605(01)00560-8 10.3390/jcm8070987 10.3390/molecules21081063 10.1016/j.jaad.2006.08.048 10.1016/0168-1605(95)00055-0 10.1210/edrv.21.4.0404 10.3389/fimmu.2013.00507 10.1038/nrmicro2537 10.1517/14740338.2013.740456 10.1021/acs.biomac.9b00939 10.1074/jbc.M112.359067 10.1007/978-3-642-20838-6_9 10.1001/jamadermatol.2017.1297 10.1159/000338978 10.1128/AAC.33.3.326 10.1111/j.1600-0846.2011.00605.x 10.1016/j.tifs.2018.03.009 10.1086/432067 10.1080/00015550310016463 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 MDPI AG |
Copyright_xml | – notice: COPYRIGHT 2020 MDPI AG |
DBID | AAYXX CITATION DOA |
DOI | 10.3390/cosmetics7030070 |
DatabaseName | CrossRef DOAJ Open Access Full Text |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 2079-9284 |
ExternalDocumentID | oai_doaj_org_article_a019a8864b174e94900e2c783d40244f A646516291 10_3390_cosmetics7030070 |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | 5VS 8FE 8FH AADQD AAFWJ AAHBH AAYXX ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS BBNVY BCNDV BENPR BHPHI CCPQU CITATION GROUPED_DOAJ HCIFZ IAO KQ8 LK8 M7P MODMG M~E OK1 PHGZM PHGZT PIMPY PQGLB PROAC PUEGO |
ID | FETCH-LOGICAL-c379t-1333d5fc006dd1b743163ef8886c9666daaf56e6a862b625a63ddbf4672954593 |
IEDL.DBID | DOA |
ISSN | 2079-9284 |
IngestDate | Wed Aug 27 01:30:11 EDT 2025 Tue Jun 17 22:05:05 EDT 2025 Thu Apr 24 22:56:52 EDT 2025 Wed Sep 10 05:54:06 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c379t-1333d5fc006dd1b743163ef8886c9666daaf56e6a862b625a63ddbf4672954593 |
ORCID | 0000-0001-7190-6385 0000-0001-9470-4110 0000-0001-6400-8245 0000-0003-2928-1726 |
OpenAccessLink | https://doaj.org/article/a019a8864b174e94900e2c783d40244f |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a019a8864b174e94900e2c783d40244f gale_infotracmisc_A646516291 crossref_primary_10_3390_cosmetics7030070 crossref_citationtrail_10_3390_cosmetics7030070 |
PublicationCentury | 2000 |
PublicationDate | 2020-09-01 |
PublicationDateYYYYMMDD | 2020-09-01 |
PublicationDate_xml | – month: 09 year: 2020 text: 2020-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Cosmetics (Basel) |
PublicationYear | 2020 |
Publisher | MDPI AG |
Publisher_xml | – name: MDPI AG |
References | Yang (ref_27) 2014; 5 Fried (ref_33) 2006; 19 Lee (ref_28) 2001; 32 Mankoci (ref_42) 2019; 20 Tripathi (ref_34) 2013; 12 Messi (ref_25) 2003; 220 See (ref_10) 2018; 45 ref_19 Coughlin (ref_41) 2017; 34 ref_15 Wormser (ref_31) 2005; 41 Webster (ref_38) 2005; 76 Brown (ref_2) 1998; 351 Leyden (ref_24) 2004; 73 Cooper (ref_7) 2017; 206 Tester (ref_16) 2012; 1 Cleveland (ref_22) 2001; 71 ref_29 Rad (ref_53) 2020; 10 Jappe (ref_9) 2003; 83 Vermeer (ref_44) 2012; 287 Tanghetti (ref_8) 2013; 6 Patel (ref_20) 2013; 40 Bagatin (ref_4) 2014; 89 Nast (ref_12) 2012; 26 Garcia (ref_18) 2018; 75 ref_32 Sakuma (ref_50) 2012; 25 Naik (ref_17) 2012; 337 Palm (ref_40) 2015; 159 Cobacho (ref_30) 2017; 22 Fluhr (ref_13) 2010; 8 ref_37 Deplewski (ref_47) 2000; 21 Brown (ref_45) 2014; 4 Kober (ref_39) 2015; 1 Kanlayavattanakul (ref_35) 2011; 33 Cunliffe (ref_1) 1979; 1 Strauss (ref_11) 2007; 56 Decker (ref_14) 1989; 33 Tan (ref_3) 2015; 172 ref_43 Dobson (ref_26) 2012; 78 Kim (ref_51) 2013; 19 Adler (ref_23) 2017; 153 Grice (ref_52) 2011; 9 Abee (ref_21) 1995; 28 ref_49 Bagatin (ref_36) 2014; 13 Toyoda (ref_5) 2001; 34 Kang (ref_46) 2009; 47 ref_6 Makrantonaki (ref_48) 2011; 3 |
References_xml | – volume: 19 start-page: 237 year: 2006 ident: ref_33 article-title: Psychological problems in the acne patient publication-title: Dermatol. Ther. doi: 10.1111/j.1529-8019.2006.00079.x – ident: ref_32 – ident: ref_49 doi: 10.1016/B978-0-12-812475-8.00004-4 – volume: 45 start-page: 522 year: 2018 ident: ref_10 article-title: Optimizing the use of topical retinoids in Asian acne patients publication-title: J. Dermatol. doi: 10.1111/1346-8138.14314 – volume: 40 start-page: 11 year: 2013 ident: ref_20 article-title: Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: What is the current evidence? publication-title: Clin. Perinatol. doi: 10.1016/j.clp.2012.12.002 – volume: 78 start-page: 1 year: 2012 ident: ref_26 article-title: Bacteriocin production: A probiotic trait? publication-title: Appl. Environ. Microbiol. doi: 10.1128/AEM.05576-11 – volume: 3 start-page: 41 year: 2011 ident: ref_48 article-title: An update on the role of the sebaceous gland in the pathogenesis of acne publication-title: Dermatoendocrinol doi: 10.4161/derm.3.1.13900 – volume: 337 start-page: 1115 year: 2012 ident: ref_17 article-title: Compartmentalized control of skin immunity by resident commensals publication-title: Science doi: 10.1126/science.1225152 – volume: 220 start-page: 121 year: 2003 ident: ref_25 article-title: Bacteriocin-like substance (BLS) production in Aeromonas hydrophila water isolates publication-title: FEMS Microbiol. Lett. doi: 10.1016/S0378-1097(03)00092-2 – volume: 47 start-page: 101 year: 2009 ident: ref_46 article-title: Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect publication-title: J. Microbiol. doi: 10.1007/s12275-008-0179-y – volume: 206 start-page: 41 year: 2017 ident: ref_7 article-title: Modern management of acne publication-title: Med. J. Aust. doi: 10.5694/mja16.00516 – volume: 34 start-page: 661 year: 2017 ident: ref_41 article-title: The preadolescent acne microbiome: A prospective, randomized, pilot study investigating characterization and effects of acne therapy publication-title: Pediatr. Dermatol. doi: 10.1111/pde.13261 – volume: 8 start-page: S24 year: 2010 ident: ref_13 article-title: Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy publication-title: J. Dtsch. Dermatol. Ges. – volume: 32 start-page: 146 year: 2001 ident: ref_28 article-title: Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus publication-title: Lett. Appl. Microbiol. doi: 10.1046/j.1472-765x.2001.00876.x – volume: 10 start-page: 3 year: 2020 ident: ref_53 article-title: Postbiotics as novel health-promoting ingredients in functional foods publication-title: Health Promot. Perspect. doi: 10.15171/hpp.2020.02 – volume: 1 start-page: 5 year: 2012 ident: ref_16 article-title: The role of pre-and probiotics in skin care publication-title: Inside Cosmeceuticals – ident: ref_19 doi: 10.3390/ijms20194673 – volume: 33 start-page: 289 year: 2011 ident: ref_35 article-title: Therapeutic agents and herbs in topical application for acne treatment publication-title: Int. J. Cosmet. Sci. doi: 10.1111/j.1468-2494.2011.00647.x – volume: 22 start-page: 234 year: 2017 ident: ref_30 article-title: The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2016.10.017 – volume: 89 start-page: 428 year: 2014 ident: ref_4 article-title: Acne vulgaris: Prevalence and clinical forms in adolescents from Sao Paulo, Brazil publication-title: An. Bras. Dermatol. doi: 10.1590/abd1806-4841.20142100 – volume: 159 start-page: 122 year: 2015 ident: ref_40 article-title: Immune-microbiota interactions in health and disease publication-title: Clin. Immunol. doi: 10.1016/j.clim.2015.05.014 – volume: 1 start-page: 85 year: 2015 ident: ref_39 article-title: The effect of probiotics on immune regulation, acne, and photoaging publication-title: Int. J. Women Dermatol. doi: 10.1016/j.ijwd.2015.02.001 – volume: 34 start-page: 29 year: 2001 ident: ref_5 article-title: Pathogenesis of acne publication-title: Med. Electron. Microsc. doi: 10.1007/s007950100002 – volume: 1 start-page: 1109 year: 1979 ident: ref_1 article-title: Prevalence of facial acne vulgaris in late adolescence and in adults publication-title: Br. Med. J. doi: 10.1136/bmj.1.6171.1109 – volume: 5 start-page: 241 year: 2014 ident: ref_27 article-title: Antibacterial activities of bacteriocins: Application in foods and pharmaceuticals publication-title: Front. Microbiol. – volume: 172 start-page: 3 year: 2015 ident: ref_3 article-title: A global perspective on the epidemiology of acne publication-title: Br. J. Dermatol. doi: 10.1111/bjd.13462 – volume: 351 start-page: 1871 year: 1998 ident: ref_2 article-title: Acne vulgaris publication-title: Lancet doi: 10.1016/S0140-6736(98)01046-0 – volume: 26 start-page: 1 year: 2012 ident: ref_12 article-title: European evidence-based (S3) guidelines for the treatment of acne publication-title: J. Eur. Acad. Dermatol. Venereol. doi: 10.1111/j.1468-3083.2011.04374.x – volume: 73 start-page: 6 year: 2004 ident: ref_24 article-title: Antibiotic resistance in the topical treatment of acne vulgaris publication-title: Cutis – volume: 71 start-page: 1 year: 2001 ident: ref_22 article-title: Bacteriocins: Safe, natural antimicrobials for food preservation publication-title: Int. J. Food Microbiol. doi: 10.1016/S0168-1605(01)00560-8 – ident: ref_37 doi: 10.3390/jcm8070987 – ident: ref_15 doi: 10.3390/molecules21081063 – volume: 76 start-page: 4 year: 2005 ident: ref_38 article-title: The pathophysiology of acne publication-title: Cutis – volume: 56 start-page: 651 year: 2007 ident: ref_11 article-title: Guidelines of care for acne vulgaris management publication-title: J. Am. Acad. Dermatol. doi: 10.1016/j.jaad.2006.08.048 – volume: 28 start-page: 169 year: 1995 ident: ref_21 article-title: Bacteriocins: Modes of action and potentials in food preservation and control of food poisoning publication-title: Int. J. Food Microbiol. doi: 10.1016/0168-1605(95)00055-0 – volume: 21 start-page: 363 year: 2000 ident: ref_47 article-title: Role of hormones in pilosebaceous unit development publication-title: Endocr. Rev. doi: 10.1210/edrv.21.4.0404 – volume: 4 start-page: 507 year: 2014 ident: ref_45 article-title: Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design publication-title: Front. Immunol. doi: 10.3389/fimmu.2013.00507 – volume: 9 start-page: 244 year: 2011 ident: ref_52 article-title: The skin microbiome publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro2537 – volume: 12 start-page: 39 year: 2013 ident: ref_34 article-title: Side effects of common acne treatments publication-title: Expert Opin. Drug Saf. doi: 10.1517/14740338.2013.740456 – volume: 20 start-page: 4096 year: 2019 ident: ref_42 article-title: Bacterial Membrane Selective Antimicrobial Peptide-Mimetic Polyurethanes: Structure–Property Correlations and Mechanisms of Action publication-title: Biomacromolecules doi: 10.1021/acs.biomac.9b00939 – ident: ref_6 – ident: ref_29 – volume: 13 start-page: 162 year: 2014 ident: ref_36 article-title: Acne vulgaris: An inflammatory disease even before the onset of clinical lesions publication-title: Inflamm. Allergy-Drug Targets (Former. Curr. Drug Targets-Inflamm. Allergy) – volume: 287 start-page: 34120 year: 2012 ident: ref_44 article-title: Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic alpha-helical peptides publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.359067 – ident: ref_43 doi: 10.1007/978-3-642-20838-6_9 – volume: 6 start-page: 27 year: 2013 ident: ref_8 article-title: The role of inflammation in the pathology of acne publication-title: J. Clin. Aesthetic Dermatol. – volume: 153 start-page: 810 year: 2017 ident: ref_23 article-title: Antibiotic Resistance in Acne Treatment publication-title: JAMA Dermatol. doi: 10.1001/jamadermatol.2017.1297 – volume: 25 start-page: 227 year: 2012 ident: ref_50 article-title: Oily skin: An overview publication-title: Skin Pharmacol. Physiol. doi: 10.1159/000338978 – volume: 33 start-page: 326 year: 1989 ident: ref_14 article-title: Role of lipids in augmenting the antibacterial activity of benzoyl peroxide against Propionibacterium acnes publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.33.3.326 – volume: 19 start-page: e45 year: 2013 ident: ref_51 article-title: Sebum, acne, skin elasticity, and gender difference–which is the major influencing factor for facial pores? publication-title: Skin Res. Technol. doi: 10.1111/j.1600-0846.2011.00605.x – volume: 75 start-page: 105 year: 2018 ident: ref_18 article-title: Postbiotics: An evolving term within the functional foods field publication-title: Trends Food Sci. Technol. doi: 10.1016/j.tifs.2018.03.009 – volume: 41 start-page: 577 year: 2005 ident: ref_31 article-title: Antibiotics in Laboratory Medicine, Edited by Victor Lorain Philadelphia: Lippincott Williams & Wilkins, 2005 832 pp., illustrated. $199.00 (cloth) publication-title: Clin. Infect. Dis. doi: 10.1086/432067 – volume: 83 start-page: 241 year: 2003 ident: ref_9 article-title: Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy publication-title: Acta Derm. Venereol. doi: 10.1080/00015550310016463 |
SSID | ssj0001325319 |
Score | 2.3758147 |
Snippet | Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and... |
SourceID | doaj gale crossref |
SourceType | Open Website Aggregation Database Enrichment Source Index Database |
StartPage | 70 |
SubjectTerms | Acne Allergy antiacne Antiacne agents benzoyl peroxide Care and treatment Composition LactoSporin Methods postbiotics primary skin irritation patch test Skin Testing |
Title | Novel Topical Application of a Postbiotic, LactoSporin®, in Mild to Moderate Acne: A Randomized, Comparative Clinical Study to Evaluate its Efficacy, Tolerability and Safety |
URI | https://doaj.org/article/a019a8864b174e94900e2c783d40244f |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LTtwwFLUqdl1ULQV1KKC7YIM00YQ49sTsUjQIVYUFD4ld5KcUKSSICUjDR_ERfFnvTQJELOimy0SOY9nX9jnxzTmM7QmfKaO4jtw8zqI0tT5SwpiIu9h4JBSIGLpsizN5cpX-vhbXI6svygnr5YH7jptpxCA6y2RqEDt7lao49omdZ9wh80nTQKtvrOIRmeq-rvCEgqs_l-TI62e2Wd7Qb4FLCvGYvIlH-1An1z8syqPt5fgr-zLgQsj79nxjn3y9zj6P1AK_s6ez5sFXcNncUsdC_nb0DE0ADeS7a8oGK5jCH7LRIQfzsn5-mkJZw2lZOWgb6MzPEGBCbmt_CDmc69o1N-Wjd1M4etMCh0ExtAJKNVzRo4teGdxD2S5hQdoT2q6m2KAKa-ySbFeAlcGFDr5dbbCr48Xl0Uk02C1Els8VmdJz7kSwOA-dOzAELST3ASmytEiKpNM6COmlRhJkkDZpyZ0zAVdaOisUim-ytbqp_Q8G0iJhFyKYFOEWUR4ZEscdXYdEJGbCZi-dX9hBi5wsMaoCOQkNV_F-uCZs__WJ216H44Oyv2g8X8uRgnZ3A-OqGOKq-FdcTdg2RUNB8xybZnHW2SKXZB0vE3Ww9T_e8ZO-ElAWEKWsbbO19u7e7yDGac1uF85_ASmX-kU |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+Topical+Application+of+a+Postbiotic%2C+LactoSporin%C2%AE%2C+in+Mild+to+Moderate+Acne%3A+A+Randomized%2C+Comparative+Clinical+Study+to+Evaluate+its+Efficacy%2C+Tolerability+and+Safety&rft.jtitle=Cosmetics+%28Basel%29&rft.au=Muhammed+Majeed&rft.au=Shaheen+Majeed&rft.au=Kalyanam+Nagabhushanam&rft.au=Lakshmi+Mundkur&rft.date=2020-09-01&rft.pub=MDPI+AG&rft.eissn=2079-9284&rft.volume=7&rft.issue=3&rft.spage=70&rft_id=info:doi/10.3390%2Fcosmetics7030070&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_a019a8864b174e94900e2c783d40244f |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2079-9284&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2079-9284&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2079-9284&client=summon |